Detalles de la búsqueda
1.
TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.
Proc Natl Acad Sci U S A
; 117(49): 31331-31342, 2020 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33214146
2.
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice.
J Allergy Clin Immunol
; 149(4): 1413-1427.e2, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34506849
3.
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res
; 23(1): 202, 2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945604
4.
Adverse outcomes of frailty in the elderly: the Rotterdam Study.
Eur J Epidemiol
; 29(6): 419-27, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24935872
5.
STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity.
J Exp Med
; 220(9)2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347461
6.
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.
Sci Transl Med
; 15(710): eadi0252, 2023 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611083
7.
Range of motion in femoroacetabular impingement.
Acta Orthop Belg
; 78(3): 327-32, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22822572
8.
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.
Cell Rep Med
; 3(12): 100833, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459994
9.
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
J Exp Med
; 219(2)2022 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914824
10.
A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism.
Cell Rep
; 36(12): 109748, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551300
11.
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med
; 9(12): 1427-1438, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756178
12.
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 556, 2020 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571394
13.
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 554, 2020 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571428
14.
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 468, 2020 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493441
15.
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 491, 2020 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32503663
16.
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
Front Immunol
; 11: 596761, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329586
17.
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 934, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213529
18.
Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation.
Cell Rep
; 29(9): 2689-2701.e4, 2019 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31775038
Resultados
1 -
18
de 18
1
Próxima >
>>